BioSphere Medical, Inc. Schedules Fourth Quarter 2009 Financial Results Conference Call February 11

ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, today announced that it plans to issue its financial results for the fourth quarter ended December 31, 2009 on February 10 after the close of the stock market. Management will conduct a conference call on Thursday, February 11 at 8:30 a.m. Eastern time to discuss these results.

Back to news